Reaktionsgleichung
[C:1]([NH:9][CH:10]([C:15]([OH:17])=O)[CH2:11][CH2:12][S:13][CH3:14])(=[O:8])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.[Cl:18][C:19]1[CH:24]=[CH:23][C:22]([C:25]2([OH:31])[CH2:30][CH2:29][NH:28][CH2:27][CH2:26]2)=[CH:21][CH:20]=1.C(NC(C(O)=O)C(C)C)(=O)C1C=CC=CC=1.Cl.ClC1C=CC(C2CCNCC2)=CC=1>>[Cl:18][C:19]1[CH:24]=[CH:23][C:22]([C:25]2([OH:31])[CH2:26][CH2:27][N:28]([C:15](=[O:17])[CH:10]([NH:9][C:1](=[O:8])[C:2]3[CH:3]=[CH:4][CH:5]=[CH:6][CH:7]=3)[CH2:11][CH2:12][S:13][CH3:14])[CH2:29][CH2:30]2)=[CH:21][CH:20]=1Komponenten
5
Edukt 4
Produkt 1
Versuchsvorschrift
Example 217 was prepared in a similar manner as described for the preparation of Example 208 with the exceptions that benzoyl-DL-methionine and 4-(4-chlorophenyl)-4-hydroxypiperidine were substituted for benzoyl-DL-valine and 4-(4-chlorophenyl)piperidine hydrochloride, respectively. MS found: (M+H)+=448.
Aufarbeitung
- customExample 217 was prepared in a similar manner
Quellen und Nachweise
- ORD-Eintrag
- ord-54dde8d92b244532a474e24aaaae48ed
- Quelldatensatz
- uspto-grants-2009_10
- Patentnummer
- US07601844B2
Verknüpfte Notizen
Wird geladen…